Anti-inhibitor coagulant complex Completed Phase 3 Trials for Hemophilia A or B With Inhibitors / Hemophilia B / Hemophilia A Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00851721Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor